Document Actions
Document Actions

Volunteers needed for international study on depression

last modified 29/04/2009 14:25

By year 2020, depression will be the second biggest disease burden (after cardiovascular disease). However no reliable objective tool yet exists to support clinical decisions.

The prescription of anti-depression medication for example can be difficult because there are no evidence-based biological tests to ensure that people receive the type of medication that they will respond best to.

iSPOT-D is the largest international study ever undertaken into Major Depressive Disorder (MDD) that aims to find objective biological markers to identify depression and treatment outcomes.

For further information on this study contact Acacia House (02) 9845 8195, Fax (02) 9845 8190 or email brain.dynamics@usyd.edu.au